Market closedNon-fractional

IceCure Medical/ICCM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About IceCure Medical

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Ticker

ICCM

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Caesarea, Israel

Employees

74

IceCure Medical Metrics

BasicAdvanced
$35M
Market cap
-
P/E ratio
-$0.32
EPS
2.90
Beta
-
Dividend rate
$35M
2.9
3.392
2.71
2.681
4.718
-44.46%
-86.15%
10.276
3
3
-2.641
7.02%
-24.05%
-9.33%
10.84%

What the Analysts think about IceCure Medical

Analyst Ratings

Majority rating from 4 analysts.
Buy

IceCure Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-514.28% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$700K
-41.67%
Net income
-$3.6M
24.14%
Profit margin
-514.28%
112.81%

IceCure Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.08
-$0.09
-$0.07
-$0.08
-
Expected
-$0.09
-$0.09
-$0.07
-$0.08
-$0.07
Surprise
-7.69%
-3.33%
-7.14%
0.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IceCure Medical stock?

IceCure Medical (ICCM) has a market cap of $35M as of July 06, 2024.

What is the P/E ratio for IceCure Medical stock?

The price to earnings (P/E) ratio for IceCure Medical (ICCM) stock is 0 as of July 06, 2024.

Does IceCure Medical stock pay dividends?

No, IceCure Medical (ICCM) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next IceCure Medical dividend payment date?

IceCure Medical (ICCM) stock does not pay dividends to its shareholders.

What is the beta indicator for IceCure Medical?

IceCure Medical (ICCM) has a beta rating of 2.9. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell IceCure Medical stock

Buy or sell IceCure Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing